Beranda › PPOK › South Carolina › Spartanburg
Uji klinis PPOK di Spartanburg, SC
5 studi untuk PPOK mencari peserta di lokasi sekitar Spartanburg (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Menerima pesertaFase 3
- GSK Investigational Site, Spartanburg
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Menerima pesertaFase 3
- Research Site, Spartanburg
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Menerima pesertaFase 2
- Research Site, Spartanburg
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Menerima pesertaFase 3
- Research Site, Spartanburg
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Menerima pesertaFase 2/3
- Velocity Clinical Research, Spartanburg, Spartanburg
Uji klinis PPOK di kota lain
- Philadelphia, PA24 studi
- Miami, FL18 studi
- Birmingham, AL17 studi
- Boston, MA17 studi
- Houston, TX16 studi
- Baltimore, MD15 studi
- Orlando, FL15 studi
- Chicago, IL15 studi
- Dallas, TX13 studi
- Pittsburgh, PA12 studi
- New York City, NY11 studi
- Ann Arbor, MI10 studi
Studi lain di Spartanburg
- Kanker Paru7 studi
- Kanker Payudara6 studi
- Leukemia Mieloid Akut6 studi
- Kanker Paru Non-Sel Kecil6 studi
- Obesitas6 studi
- Kanker Kolorektal6 studi
- Kanker Prostat5 studi
- Kelebihan Berat Badan5 studi
- Kanker Ovarium4 studi
- Gagal Ginjal3 studi
- Diabetes3 studi
- Dermatitis Atopik (Eksim)3 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.